WEINREB, ON BEHALF OF THE CONFOCAL SCANNING LASER OPHTHALMOSCOPY ANCILLARY STUDY TO THE OCULAR HYPERTENSION TREATMENT STUDY PURPOSE: To compare rates of topographic change in ocular hypertensive eyes in which primary open-angle glaucoma (POAG) does or does not develop, and to identify factors that influence the rate of change. DESIGN: Longitudinal, randomized clinical trial. METHODS: Four hundred forty-one participants (832 eyes) in the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment
D ETECTION OF GLAUCOMATOUS CHANGE IS ONE of the most challenging aspects of the clinical assessment of ocular hypertensive and glaucoma patients. The ability to differentiate between eyes that are progressing rapidly and eyes that are progressing slowly is important for the appropriate management of patients with glaucoma. Patients with rapidly progressing glaucoma may require adjustments to the treatment regimen to prevent the development of significant visual impairment, depending on their age and life expectancy. Alternatively, patients with slowly progressing disease may require less aggressive treatment when significant visual dysfunction is not expected in their lifetimes.
New image analysis techniques have improved our ability to identify structural change and, most importantly, to measure the rate of optic disc and retinal nerve fiber layer changes. Although imaging instruments have been available for almost 20 years, there is a paucity of information on the rate of structural change in patients with ocular hypertension. [1] [2] [3] [4] [5] Because glaucoma is a slowly progressing disease that occurs in a relatively small proportion of ocular hypertensive patients, studies investigating structural change over time in ocular hypertensive patients require extensive follow-up and a large population. The Confocal Scanning Laser Ophthalmoscopy (CSLO) Ancillary Study to the Ocular Hypertensive Treatment Study (OHTS) was initiated in 1995 with annual CSLO imaging through 2009 to provide the long-term follow-up necessary to characterize structural change over time in ocular hypertensive patients. [6] [7] [8] [9] The purpose of the present study was to compare rates of change in topographic optic disc parameters in eyes in which primary open-angle glaucoma (POAG) developed with those eyes in which POAG did not develop and to evaluate factors that influence the rate of structural change.
METHODS

PARTICIPANTS INCLUDED IN THIS REPORT MET THE OHTS
inclusion and exclusion criteria 10 and participated in the CSLO Ancillary Study to the OHTS with at least 1 good-quality Heidelberg Retina Tomograph image during follow-up. Seven OHTS clinics participated in the CSLO Ancillary Study to the OHTS: Hamilton Glaucoma Center, University of California, San Diego, California; New York Eye and Ear Infirmary, New York, New York; Devers Eye Institute, Portland, Oregon; Henry Ford Medical Center, Troy, Michigan; Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California; University of California, Davis, Davis, California; and Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania. The OHTS clinical trial registration number (ClinicalTrials.gov) is NCT00000125. The CSLO ancillary study to the OHTS was conducted in compliance with the institutional review board requirements at each study center and the Health Insurance Portability and Accountability Act. Written informed consent for participation in this ancillary study was obtained from all participants before enrollment.
OHTS eligibility criteria required participants to have an intraocular pressure (IOP) ranging from 24 to 32 mm Hg in at least 1 eye and from 21 to 32 mm Hg in the fellow eye, as well as 2 normal, reliable automated achromatic 30-2 full threshold visual fields (Carl-Zeiss-Meditec, Dublin, California, USA) together with normal-appearing optic discs based on clinical examination and review of stereoscopic optic disc photographs. 10 The optic disc reading center graders assessed photographs and estimated horizontal and vertical cup-to-disc ratios by contour.
The development of POAG, the primary endpoint for OHTS, was defined as a confirmed visual field abnormality or a confirmed clinically significant stereophotographbased optic disc deterioration attributed to POAG by a masked endpoint committee. 10 Specifically, the endpoint committee reviewed all confirmed visual field abnormalities and confirmed disc progression to determine whether the change was most probably the result of POAG, most probably not the result of POAG, or, in the case of disc progression, whether the progression was not clinically significant or an artifact. Endpoint committee members, masked as to treatment history, reviewed baseline and follow-up case report forms, visual fields, and stereoscopic disc photographs of both eyes. The first date of 3 consecutive abnormal visual fields or the first date of 2 consecutive sets of stereophotographs that classified the eye as reaching a POAG endpoint was used as the date for a POAG endpoint in all analyses.
As described previously, 6-9 3 10-degree images were obtained from both eyes and 3 15-degree Heidelberg Retina Tomograph (HRT; Heidelberg Engineering GmbH, Heidelberg, Germany) images were obtained from the right eye at the annual OHTS dilated fundus examination. If both 10-degree and 15-degree good-quality images were available, the 10-degree images were used in this analysis. The scans were obtained using the HRT 1 classic instrument throughout the study and were analyzed using software version 3.0. Corneal curvature measurements were used to correct images for magnification error. Corrective lenses were used during image acquisition when astigmatism was more than 1 diopter. The mean of 3 images was used for statistical analyses. As described previously, the CSLO Reading Center at the University of California, San Diego, conducted all quality assessment and image processing and certified all operators at every site according to standard protocols. 9 In brief, CSLO Reading Center staff reviewed each image series (images at 32 consecutive focal planes) for clarity, appropriate focus and depth adjustment, and minimal eye movement. In addition, each mean topography image was monitored for adequate reproducibility (standard deviation of the mean image, <50 mm). Of a total of 7556 right and left eye testing sessions, data for 461 (6.1%) sessions were excluded from the analysis because of poor-quality images.
Because the CSLO Ancillary Study to the OHTS was funded after the initiation of enrollment in OHTS, 77% of participants completed their first CSLO examination visit after their OHTS baseline randomization visit. 6, 7 For this reason, 7 participants with documented optic disc deterioration or visual field abnormality that subsequently was confirmed and attributed to POAG at or before their first CSLO imaging session were excluded from the analysis. The current report includes all goodquality images from the first CSLO visit to the closure date for the OHTS (March 2009) or to the first suspicious date of POAG, whichever was first.
The rate of topographic change was measured using the following CSLO stereometric parameters: rim area and volume, cup area and volume, rim-to-disc area ratio, mean cup depth, retinal nerve fiber layer (RNFL) thickness and cross-sectional area, and cup shape. Contour lines outlining the disc margin of the baseline image, necessary for calculating stereometric parameters, were drawn by certified operators at the University of California, San Diego, CSLO Reading Center while viewing a copy of stereoscopic optic disc photographs from the OHTS Optic Disc Reading Center. 9 HRT software automatically places the contour line on all follow-up images. Reference planebased stereometric parameters were measured relative to the standard reference plane calculated 50 mm posterior to the mean height contour along a small temporal section of the contour line. The standard deviation of the mean image was used as a measure of image quality and was included as a covariate with repeated measures in multivariate models. Measurements of rim area also were evaluated in 6 sectors. The 6 sectors defined using standard HRT software are not of equal size; the temporal inferior, temporal superior, nasal superior, and nasal inferior sectors are each 45 degrees, whereas the temporal and nasal sectors are each 90 degrees.
In addition, the rate of change of the glaucoma probability score was calculated. This measure does not require a reference plane and is operator independent because it does not depend on an operator-drawn contour line to outline the disc margin. As described previously, the glaucoma probability score is based on a geometric model of 5 parameters (cup size, cup depth, rim steepness, horizontal retinal nerve fiber layer curvature, and vertical retinal nerve fiber layer curvature) that describes the shape of the optic disc and parapapillary retina (globally and locally). 7 These parameters then are used as inputs to a relevance vector machine classifier, and the resulting output is summarized as the probability (between 0% and 100%) that the eye is glaucomatous (based on fit-to-training data from healthy and glaucoma eyes).
STATISTICAL ANALYSIS: The final OHTS and CSLO analysis data sets include all OHTS and CSLO data and POAG endpoints with initial suspicious dates that were confirmed and entered into the database by March 2009. The primary analysis compares the rate of topographic change in eyes in which POAG endpoints developed and eyes in which POAG endpoints did not develop, as determined by the endpoint committee. In addition, the rate of HRT topographic rate of change was estimated in those eyes that developed (1) an initial optic disc POAG endpoint only, (2) an initial visual field POAG endpoint and (3) reproducible optic disc change as determined by the OHTS Optic Disc Reading Center, including those not considered as POAG endpoints by the endpoint committee. Specifically, eyes determined to have optic disc progression by the OHTS Optic Disc Reading Center included eyes classified by the endpoint committee as an OHTS optic disc POAG endpoint (most probably the result of POAG), as well as eyes not considered a optic disc POAG endpoint (most probably not the result of POAG or not clinically significant or an artifact). For participants in whom unilateral POAG developed, only the POAG eye was included in the analysis.
All descriptive tables (means and percentages) of ophthalmic measures include the right and left eyes separately because each eye was used in the multivariate analysis. To compare patient-specific categorical variables (race, gender, family history of glaucoma, and randomization assignment to treatment arm) of participants who did or did not develop POAG, we used the Fisher exact test. Continuous variables (age, baseline visual field pattern standard deviation [PSD], baseline visual field mean deviation, central corneal thickness, baseline IOP, and baseline rim area) in eyes that did or did not develop POAG were compared using the Wilcoxon rank-sum test.
Mixed effects modeling 11 was used to evaluate the relationship between HRT measurements and POAG status over time in univariate and multivariate models. Initially, in what we considered univariate analysis, we compared rates of topographic change in POAG versus non-POAG eyes without adjusting for any covariates. These univariate or single-covariate models included time, POAG, and an interaction term (time 3 POAG). Subsequently, we built 8 multivariate mixed-effects models that evaluated the influence of the following 8 covariates: randomization to medication, race, baseline age, central corneal thickness baseline visual field PSD, IOP (as repeated measures), disc area, and image quality (standard deviation of the mean topography) on the rate of rim area change. IOP and standard deviation of the mean image height were included as covariates with repeated measures in the multivariate models. These covariates were chosen for analysis based on their importance in previous publications on their effect on the development of glaucoma 6,10,12 and their statistical significance in the univariate models. In multivariate models, appropriate 2-way interactions (e.g., covariate 3 time) and 3-way interactions (covariate 3 time 3 POAG) were studied to understand any multifactorial relationships. Mixed effects models with random intercepts and random slopes have been used previously in this setting to adjust for within-patient correlation in measurements between eyes from the same participant and to account for repeated measurements over time. [13] [14] [15] [16] Eyes that had a single eligible HRT visit were included in the models.
A P value less than .05 was considered statistically significant. Multiple testing corrections were not applied. Statistical analyses were performed using SAS software version 9.2 (SAS Institute, Cary, North Carolina, USA) and R version 2.10.0 (http://www.r-project.org/).
RESULTS
FOUR HUNDRED FORTY-ONE PARTICIPANTS (832 EYES) IN
the CSLO Ancillary Study to the OHTS met the inclusion criteria for this report. Baseline clinical and ocular factors of the 441 CSLO Ancillary Study participants
included in this analysis are presented in Tables 1  and 2 . The mean baseline age (95% confidence interval [CI]) of the participants was 54.4 years (range, 53.5 to 55.2 years).
Fifty-two participants (11.8%; 66 eyes) developed POAG and 389 (88.2%) participants (766 eyes) did not develop POAG during the follow-up period. Rates of change were calculated for all available visits for eyes not demonstrating POAG and until the first suspicious finding for those eyes that developed POAG. The median (first quartile to third quartile) length of follow-up was 11.0 years (range, 5.2 to 12.2 years) for participants not demonstrating POAG and 5.6 years (range, 4.0 to 8.0 years) to the time participants developed POAG. The median (first quartile to third quartile) number of HRT examinations was 8.0 (range, 3 to 10 examinations) for participants not demonstrating POAG and 4.5 examinations (range, 3 to 6 examinations) for participants who developed POAG. Of the 52 participants in whom POAG developed, 14 (26.9%) developed bilateral POAG and 38 (73.1%) developed unilateral POAG after the initial CSLO measurement. For participants in whom unilateral POAG developed, only the POAG eye was included in the analysis. Of the 66 POAG eyes, 20 (30.3%) eyes initially reached the endpoint based on visual fields alone, 45 (68.2%) eyes initially reached the endpoint based on stereophotographs alone, and 1 (1.5%) eye initially reached the endpoint based on concurrent visual fields and stereophotographs. Among the 74 black participants, 12 (16%) participants (13 eyes) developed POAG.
It should be noted that of the 45 eyes that initially were classified as having POAG only on the basis of stereophotographs, 8 (17.8%) eyes went on to develop visual field damage attributable to POAG and 8 (40%) of the 20 eyes classified initially as POAG based on only visual fields later developed optic disc changes attributable to POAG. To summarize, of the 66 POAG eyes, a total of 17 (25.8%) developed both optic disc and visual field changes attributable to POAG during the study follow-up period. The primary statistical modeling classifies the eyes as demonstrating POAG or not without regard to whether the POAG endpoint(s) for an eye was determined by visual fields, optic disc, or both.
Based on the univariate mixed effects model, the mean rate of global rim area change was significantly faster (P < .0001) in eyes in which POAG developed compared with eyes in which it did not (À0.0131 mm 2 /year; 95% CI, À0.0174 to À0.0089 mm 2 /year) and À0.0026 mm 2 / year (95% CI, À0.0036 to À0.0015 mm 2 /year), respectively (Table 3 ). There was a broad distribution in rim area slopes, ranging from À0.150 to 0.088 mm 2 /year in eyes in which POAG developed and from À0.170 to 0.1 mm 2 /year in eyes in which POAG did not develop ( Figure 1 ). Among eyes that were in the fastest quartile of rim area loss (between À0.009 and À0.170 mm 2 /year), 22% developed POAG, compared with 3% to 5% in the slower 3 quartiles. In addition, the rate of rim area change was significantly faster in each of the 6 rim area regions (temporal, temporal inferior, temporal superior, nasal, nasal inferior, and nasal superior) in eyes in which POAG developed compared with eyes in which it did not (P < .05 for each region; Figure 2 ).
We also investigated the rate of change as a percentage of the baseline values. Eyes that developed POAG had a mean baseline rim area of 1.12 mm 2 and the mean percentage decrease from baseline rim area was 0.99%/year (95% CI, 0.74% to 1.23%/year); in eyes in which POAG did not develop (mean baseline rim area, 1.39 mm 2 ), this rate represents an overall mean percentage rim area decrease of 0.18%/year (95% CI, 0.14% to 0.21%/year).
In eyes that did not develop POAG, we also found statistically significant rates of rim area decrease over time globally as well as in each of the 6 regions. Specifically, in univariate models, the average rate of change in global rim area (À0.0026 mm 2 /year; P < .0001) and rim area in the temporal inferior (À0.0005 mm 2 /year; P < .0001), nasal inferior (À0.0002 mm 2 /year; P ¼ .0027), temporal superior (À0.0006 mm 2 /year; P < .0001), nasal superior (À0.0002 mm 2 /year; P < .0001), temporal (À0.0007 mm 2 / year; P ¼ .0034), and nasal regions (À0.0004 mm 2 /year; P ¼ .0061) were significantly less than 0.
Among participants who developed POAG, the mean rate of rim area change over time was significantly (P ¼ .0262) faster in black participants (À0.0182 mm 2 /year; 95% CI, À0.0256 to À0.0107 mm 2 /year) compared with other participants (À0.0116 mm 2 /year; 95% CI, À0.0166 to 0.0065 mm 2 /year; Figure 3 ). Among those who did not develop POAG during the study period, the rate of rim area change was similar in black participants (À0.0024 mm 2 /year; 95% CI, À0.0048 to À0.0000 mm 2 / year) and other participants (À0.0026 mm 2 /year; 95% CI, À0.0038 to À0.0014 mm 2 /year; Figure 3 ). To see this difference, refer to Figure 3 : among eyes with POAG, black persons had a faster rate of rim area loss. However, when both race and disc area were included in the same multivariate model to explain the rate of change over time, only disc area remained significantly associated with the rate of rim area change; the P value for the interaction term of time with disc area was P ¼ .0004 and was P ¼ .6655 for the interaction term of time with race (Table 4) .
We evaluated the effect of 8 covariates (randomization assignment to treatment arm, race, baseline age, central corneal thickness, baseline visual field PSD, IOP as a longitudinal measure, disc area, and standard deviation of the mean image) individually on the rate of rim area loss in 8 separate multivariate models that included terms that specifically measured the contribution of each of these covariates on the rate of change over time (Table 5) . Specifically, the interaction term (covariate 3 time) was included to assess whether the covariate influences the rate of change. We found that when evaluated in separate single variable models, larger disc area (P ¼ .0005), worse baseline visual field PSD (P ¼ .0001), higher IOP (as a longitudinal measure; P < .0001), and higher standard deviation of the mean image (P ¼ .0009) each were associated individually with a faster rate of rim area loss. Randomization assignment to treatment arm (P ¼ .927), race (P ¼ .3448), central corneal thickness (P ¼ .1702), and baseline age (P ¼ .3438) were not significantly associated with the rate of rim area loss ( Table 5) .
We also evaluated whether the rate of change of other topographic parameters was faster in eyes in which POAG developed compared with eyes in which POAG did not develop ( Table 6 ). In univariate analysis, the rate of change of rim volume, rim area as a percent of baseline rim area, rim-to-disc ratio, cup-to-disc ratio, mean cup depth, cup volume below surface, and glaucoma probability score probably score were significantly faster in eyes in which POAG developed compared with eyes in which it did not. The rate of change of RNFL thickness and RNFL cross-sectional area were not significantly faster in eyes in which POAG developed compared with eyes in which POAG did not develop. Among eyes that did not develop POAG, the rate of change of all topographic parameters except RNFL thickness and RNFL crosssectional area were statistically significant ( Table 6 ).
In addition, we compared the rate of topographic change in eyes that developed a visual field POAG endpoint compared with eyes that developed an optic disc POAG endpoint ( Table 7) . We found that the mean rate of rim area change was significantly (P ¼ .042) faster in eyes that reached an optic disc POAG endpoint (À0.0169 mm 2 /year; 95% CI, À0.0225 to À0.0113 mm 2 / year) compared with eyes that reached a visual field POAG endpoint (À0.0079 mm 2 /year; 95% CI, À0.0157 to À0.0001 mm 2 /year). Moreover, we measured the rate of rim area change in eyes that were considered to be progressing by the OHTS Optic Disc Reading Center that were not considered as a POAG endpoint by the endpoint committee and found that the mean change (À0.0094 mm 2 /year; 95% CI, À0.0151 to À0.0027 mm 2 / year) tended to be faster than the rate of change among eyes that reached a visual field POAG endpoint, but slower than the rate of change in eyes that reached an optic disc POAG endpoint. These differences did not reach statistical significance.
DISCUSSION
IN THIS REPORT, THE RATE OF NEURORETINAL RIM AREA loss as measured using the HRT was approximately 5 times faster in ocular hypertensive eyes in which POAG developed compared with eyes in which it did not. Moreover, we found that the rate of neuroretinal rim area loss was significantly different from 0 in eyes that did not develop POAG during the follow-up period.
Other investigators also have reported that the rate of neuroretinal rim area change is faster in ocular hypertensive eyes in which glaucomatous visual field loss develops than eyes in which it does not. Strouthidis and associates reported that the rate of rim area change (square millimeters per year) in the inferior temporal sector was 3.2 times faster in eyes with visual field progression compared with those without. 2 In the Diagnostic Innovations in Glaucoma Study, glaucoma suspects (with elevated IOP or optic disc damage at baseline) and glaucoma patients with documented glaucomatous visual field or optic disc progression had between 5 times and 8 times faster rates of retinal nerve fiber layer thinning measured with the GDx VCC and GDx ECC (Carl Zeiss Meditec, Inc, Dublin, California, USA) than eyes that were not progressing. 14, 15, [17] [18] [19] In addition, See and associates reported that the rate of global HRT neuroretinal rim area change was more than 4 times faster in glaucoma eyes than normal eyes when measured in absolute units (median, À5.33 3 10 À3 mm 2 /year and À1.25 3 10 À3 mm 2 /year, respectively; P ¼ .006) or as a percentage of baseline rim area (median, À0.42%/ year and À0.07%/year, respectively; P ¼ .001). 20 Leung and associates reported a mean rate of rim area percent change (À1.06%/year) in glaucoma patients that was similar to the rate of change reported in eyes in which POAG developed in the current study (0.99%/year). 21 In univariate analysis, we found that race was associated significantly with the rate of neuroretinal rim change in eyes in which POAG developed; black participants had a faster rate of neuroretinal rim area loss than other participants. However, the faster rate of loss in black participants compared with other racial groups in whom POAG developed largely is explained by the larger optic disc size in the black participants. After adjusting for optic disc area in the multivariate model, the racial differences in the rate of neuroretinal rim area loss are reduced and no longer are statistically significant. These results are consistent with those of our previous report and reports of other investigators demonstrating that differences in the risk of developing POAG between black and other OHTS participants are explained, at least in part, by other factors, including thinner central corneal thickness, baseline cup-to-disc ratio, and larger disc area of the black participants. 8, [22] [23] [24] [25] It is interesting to note that in previous reports of the CSLO Ancillary Study to the OHTS, baseline optic disc area was not predictive of the development of a POAG endpoint in multivariate Cox proportional hazards models. 6, 7 In the current analysis, larger disc area was associated with a faster rate of rim area loss (Table 4) in eyes in which POAG developed. One might expect that if a larger disc area was associated with a faster rate of rim area loss, then it would also be associated with the development of POAG. There are several possible explanations for the inconsistency of these results. It may be that the rate of rim area loss is measured more reproducibly in large optic discs, thereby increasing the possibility of detecting significant rates of change. This finding also may be explained in part because eyes with larger discs have a relatively larger rim area and are more likely to have more absolute rim area loss, but not a larger percentage of rim area loss compared with baseline. Specifically, we divided the disc area in tertiles and found that the mean percentage decrease from baseline rim area in eyes with relatively large discs (highest tertile, >2.07 mm 2 ) was similar to the percentage decrease from baseline rim area in the small discs (lowest tertile, <1.73 mm 2 ; À0.65%; 95% CI, À0.27% to À0.04%; and À0.43%; 95% CI, À0.74% to À0.12%), respectively. Alternatively, it may be that the disc size influenced the ability to detect glaucomatous changes in the stereophotograph-based assessment of the optic disc; perhaps a larger disc made it more difficult to detect change or to determine that it was clinically significant structural change, in which case progression in relatively large optic discs might have been underestimated by the OHTS Optic Disc Reading Center.
Our results also confirm previous reports on ocular hypertensive eyes, glaucoma suspect eyes, and eyes with early to moderate glaucoma finding that the rate of change varies by region, with the fastest neuroretinal rim change in the inferotemporal sector ( Figure 1 ). 2, 20 We also found that there is considerable rim area change detected in the temporal and nasal regions, particularly in black participants and in eyes with large discs. Other investigators also have reported significant neuroretinal rim area change measured with the HRT in the temporal region in both glaucoma eyes and normal eyes. 20 It should be noted that the standard HRT temporal and nasal sectors are larger (90 degrees each) than the other 4 sectors (45 degrees each) and may contain more nonneural tissue (blood vessels) than the other sectors. 2, 26 For these reasons, the temporal and nasal rim area loss measured in absolute units (mm 2 /year) may be greater than other sectors in part because of the larger sector size, whereas when measured in relative units (percent per year) the temporal and especially nasal sector rate of change may be smaller compared with other sectors. 26 Therefore, comparisons of the amount of change in the temporal and nasal rim area to the other 4 sectors in this study should be made with caution. However, See and associates measured neuroretinal rim area loss in 12 equal 30-degree sectors and found significant change in the temporal regions in both glaucoma and normal eyes during the 7þ years of study follow-up. 20 Investigation of the rate of temporal rim area changes using different imaging methods such as spectral-domain optical coherence tomography may elucidate whether the temporal changes are related to issues specific to CSLO imaging or to previously underestimated temporal change that occur because of progressive glaucomatous optic neuropathy. There are several possible explanations for our findings of a statistically significant but slow rate of neuroretinal rim loss in eyes in which POAG did not develop. First, these changes may represent age-related loss of retinal ganglion cells. Several investigators have documented small but significant loss of retinal nerve fiber layer and neuroretinal rim area with age from cross-sectional studies and, more recently, from longitudinal studies. 20, [27] [28] [29] Second, it is likely that the HRT is detecting topographic changes in some of the approximately 55% of eyes that were not classified as clinically significant or POAG by the endpoint committee, but were classified as progressive change based on masked assessment of stereophotographs by the OHTS Optic Disc Reading Center (Gordon M, personal communication, 2011) . The OHTS appropriately used highly specific criteria to define a reproducible change and an endpoint committee to attribute the reproducible change to POAG. In addition, reproducible changes on stereophotographs also had to be clinically significant. As shown in Table 7 , the mean rate of rim area change in the 27 eyes that were classified as changing by the OHTS Optic Disc Reading Center but were not considered to have reached a POAG endpoint by the endpoint committee was significantly faster (À0.0094 mm 2 /year; 95% CI, À0.0161 to À0.0001 mm 2 / year) than eyes not reaching a POAG endpoint (À0.0021 mm 2 /year; 95% CI, À0.0031 to À0.0011 mm 2 / year). Third, the HRT may be identifying early changes in some eyes that were not yet detectable on stereophotographs. Finally, some of the structural changes detected may represent false-positive results. The above explanations also may explain why only 22% of eyes in the fastest quartile of rim area change reached a POAG endpoint; some of this change may be age related, and some eyes may have shown change that the endpoint committee did consider a POAG endpoint.
Although the OHTS demonstrated that treatment can delay or prevent the onset of glaucoma significantly, in this report, randomization to treatment was not associated significantly with the rate of rim area change in multivariate mixed effects models. There are several possible reasons for the lack of association of the rate of rim area change with ocular hypotensive treatment. First, this study included follow-up of participants during both phases of the OHTS, through both the OHTS I (1994 through 2002), which included participants randomized to treatment and observation, and the OHTS II (2002 through 2009) at which time all participants were offered 10 Therefore, almost all participants were treated during the study follow-up period. As the results of OHTS II suggest, delaying treatment of ocular hypertension did not increase significantly the risk of POAG developing in participants with a low probability of POAG developing, a group that constitutes most participants in the OHTS. In addition, we found that higher IOP throughout the follow-up was associated with an increase in the rate of rim area loss. This indicates that in this analysis, measured IOP may serve as an indicator of the modifying effect of treatment on glaucomatous structural change. It should be noted that at baseline, the neuroretinal rim area was smaller in eyes in which POAG developed compared with eyes in which it did not. This suggests that some eyes were included in the OHTS that may have had early preclinical or preperimetric glaucoma loss that was not identified by the OHTS Optic Disc Reading Center as glaucomatous. Preperimetric glaucoma eyes may be more likely to progress than ocular hypertensive eyes, and thus show a faster rate of rim area loss.
Smaller central corneal thickness was predictive of the development of POAG in previous OHTS studies, 6, 7, 10 but showed a weak association with the rate of neuroretinal rim area loss in the current study (the interactions with time did not reach statistical significance, P ¼ .10). The lack of a significant association between the rate of rim area loss and central corneal thickness is unexpected and may be the result of the relatively small numbers of POAG eyes included in this analysis, the complex relationship among the CCT, IOP, and rim area measurements and their variability over time, or both. We know that in some eyes, changes in IOP can result in measurable changes in HRT topographic measurements and that eyes with thinner CCT tend to have lower measured IOP. 23, [30] [31] [32] Consequently, it is possible that the complex association among IOP, CCT, and HRT topographic measurements and the wide variation of CCT among OHTS participants made detection of the relationship between CCT and the rate of rim area slope difficult to detect in this study population. Further evaluation of this issue in different study populations is needed.
The number of subjects in this report is slightly higher than that in our previous reports. [6] [7] [8] [9] At study closeout in 2009, study centers transferred HRT images of participants that had not been sent previously to the University of California, San Diego, CSLO Reading Center and therefore had not been included in earlier published reports.
Limitations to this study include the relatively small number of eyes in which POAG developed, particularly among the black participants. The small numbers result in relatively large confidence intervals around the rate of change estimates, particularly when results are presented as stratified by race and sector. Despite the small numbers of eyes in which POAG developed, and therefore limited statistical power in this report, important trends were documented and rates of change estimated. To our knowledge, this report represents the longest follow-up of the largest group of ocular hypertensive subjects using optical imaging instruments. The HRT is the only optical imaging technology whose image acquisition technique has remained stable since its initial commercialization. It should be noted that we included only good-quality HRT images, and therefore our results may not be completely generalizable to the general ophthalmic community. Even within this group of good-quality images, we found that a higher standard deviation of the mean baseline image (a poorerquality image) was associated significantly with a faster rate of change. This result in part may be because glaucoma eyes tend to have a higher standard deviation of the mean topography image than nonglaucomatous eyes. 33, 34 However, including the standard deviation in the full model had almost no effect on the estimated rates of rim area change over time. It is possible that if we had included poor-quality images, then we might have expected more variability in the estimates of the stereometric parameters and a decreased likelihood that significant rates of change would be detected. In summary, the overall rate of neuroretinal rim area loss is approximately 5 times faster in eyes in which POAG developed compared with eyes in which it did not, with approximately 22% of eyes in the fastest quartile of rim area loss demonstrating POAG. Worse baseline visual field PSD, higher IOP during follow-up, and larger disc area were associated with a faster rate of rim area loss. Moreover, neuroretinal rim area loss was detected in eyes in which POAG did not develop, as well as eyes in which POAG did develop. These results suggest that measuring of the rate of structural change using CSLO can provide important information for the clinical management of ocular hypertensive patients. Further investigation is needed to determine how best to apply rate of change information to the individual ocular hypertensive patient.
